WHO ARE WE?

Professional shareholder of value-creating companies for 20 years.

Founded in 1999, the Turenne Group supports companies, start-ups, SMEs and intermediate-sized enterprises, providing equity financing at each stage of their development across all of France.

1.8 BILLIONS € UNDER MANAGEMENT

85 Professionals

70 Investors

300 Companies in portfolio

30 M€ INVESTMENT TICKET

Our Sector strategies

Presence in French regions

The Turenne Group in 1 minute

Executive Committee

Development

ESG

Compliance & Internal Control

Finance & Operations

Latest news

AstraZeneca Closes Acquisition of Amolyt Pharma
New

AstraZeneca Closes Acquisition of Amolyt Pharma
Groupe Vigier organizes its transfer with the support of Nov Relance Impact, managed by Turenne Groupe
New

Groupe Vigier organizes its transfer with the support of Nov Relance Impact, managed by Turenne Groupe
Turenne Groupe is proud to support the EPSA Group in financing its external growth.
New

Turenne Groupe is proud to support the EPSA Group in financing its external growth.
Société Générale Capital Partenaires (SGCP), Ouest Croissance, Bpifrance and Turenne Groupe renew their confidence in Demgy Group, european leader in high value-added plastics processing
New

Société Générale Capital Partenaires (SGCP), Ouest Croissance, Bpifrance and Turenne Groupe renew their confidence in Demgy Group, european [...]
PhysioAssist announces successful acquisition by Inogen Inc. to accelerate Simeox’ US market reach and beter serve a larger population of obstructive respiratory patients.
New

PhysioAssist announces successful acquisition by Inogen Inc. to accelerate Simeox’ US market reach and beter serve a larger population of [...]
Turenne Groupe launches the Next Health Capital fund and boosts its teams dedicated to healthcare innovation
Press release

Turenne Groupe launches the Next Health Capital fund and boosts its teams dedicated to healthcare innovation
Domain Therapeutics raises $42m Series A financing
Press articles

Domain Therapeutics raises $42m Series A financing
GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading French investors in the health sector
New

GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading French investors in the health sector
StromaCare has raised €1,500,000 for the development of a new oncology therapy based on the immuno-modulation of the tumor stroma using a monoclonal antibody.
New

StromaCare has raised €1,500,000 for the development of a new oncology therapy based on the immuno-modulation of the tumor stroma using a [...]
Phodé, a laboratory specialising in natural sensory solutions, reorganised its share capital with the entry of Turenne Santé as a minority shareholder
Press release

Phodé, a laboratory specialising in natural sensory solutions, reorganised its share capital with the entry of Turenne Santé as a minority [...]
Turenne Santé, supported by BNP Paribas Développement, becomes a minority shareholder in the capital of H.A.C.Pharma to support the company in its growth and strengthen the product portfolio
New

Turenne Santé, supported by BNP Paribas Développement, becomes a minority shareholder in the capital of H.A.C.Pharma to support the company in its [...]
Innovacom acquires a stake in Primo1D, world leader in smart electronic thread
New

Innovacom acquires a stake in Primo1D, world leader in smart electronic thread
All news